Conference Call and Webcast at 8:30AM Eastern Time NEW YORK, July 31, 2023 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company and majority-owned subsidiary of PAVmed Inc. (Nasdaq: PAVM, PAVMZ),...
For more information, please visit
https://www.prnewswire.com/news-releases[...]-august-15-2023-301889721.html